Diaceutics PLC
DIUXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$195.62M
Close$
$-1.52
165.9% downside
Current Fair Value
165.9% downsideOvervalued by 165.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $195.62 Million |
|---|---|
| Enterprise Value | $191.19 Million |
| Earnings per Share | $0 |
| Beta | 0.89 |
| Outstanding Shares | 84,674,884 |
Return
| Return on Equity | -4.62% |
|---|---|
| Return on Assets | -3.43% |
| Return on Invested Capital | -7.36% |
Valuation & Multiples
| P/E Ratio | -635.94 |
|---|---|
| PEG | -4149.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.52 |
| Enterprise Value to EBIT | -63.88 |
| Enterprise Value to Net Income | -107 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 22, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$23.20 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Diaceutics PLC
205 employees
CEO: Ryan Keeling
Diaceutics PLC operates as a global diagnostic commercialization entity, providing pharmaceutical companies worldwide with essential data, sophisticated analytics, and implementation support. Central to its offerings is the DXRX platform...